Raphael Marlu

Rouen, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications

Analytical and clinical validation of the Tsmart FIB Batrox© assay on the LabPad Evolution analyzer for fibrinogen measurement in whole blood.

Analytical and clinical validation of the Tsmart FIB Batrox© assay on the LabPad Evolution analyzer for fibrinogen measurement in whole blood.

Journal: Thrombosis research
Published: March 09, 2026

Screening chemical libraries for the development of oral treatments for bleeding disorders.

Screening chemical libraries for the development of oral treatments for bleeding disorders.

Journal: Blood vessels, thrombosis & hemostasis
Published: January 22, 2025

Acclimatized Lowlanders Exhibit a Hypocoagulable Profile after a Passive Ascent at High Altitude.

Acclimatized Lowlanders Exhibit a Hypocoagulable Profile after a Passive Ascent at High Altitude.

Journal: High altitude medicine & biology
Published: December 18, 2024

Effect of emicizumab on activated clotting time performed on i-STAT Alinity analyzer.

Effect of emicizumab on activated clotting time performed on i-STAT Alinity analyzer.

Journal: International journal of laboratory hematology
Published: April 18, 2024

Cross-reactivity of human anti-FVIII antibodies to porcine rFVIII: French field study to validate the modified Nijmegen method.

Cross-reactivity of human anti-FVIII antibodies to porcine rFVIII: French field study to validate the modified Nijmegen method.

Journal: International journal of laboratory hematology
Published: April 09, 2024

The administration of four-factor prothrombin complex concentrate exacerbates thrombin generation in trauma patients at risk of massive transfusion: an ancillary study of the PROCOAG trial.

The administration of four-factor prothrombin complex concentrate exacerbates thrombin generation in trauma patients at risk of massive transfusion: an ancillary study of the PROCOAG trial.

Journal: Critical care (London, England)
Published: February 02, 2024

Are coagulation profiles in Andean highlanders with excessive erythrocytosis favouring hypercoagulability?

Are coagulation profiles in Andean highlanders with excessive erythrocytosis favouring hypercoagulability?

Journal: Experimental physiology
Published: November 14, 2023

Toward non-factor therapy in hemophilia: an antithrombin insensitive Gla-domainless factor Xa as tissue factor pathway inhibitor bait.

Toward non-factor therapy in hemophilia: an antithrombin insensitive Gla-domainless factor Xa as tissue factor pathway inhibitor bait.

Journal: Research and practice in thrombosis and haemostasis
Published: February 23, 2023

Surgery in rare bleeding disorders: the prospective MARACHI study.

Surgery in rare bleeding disorders: the prospective MARACHI study.

Journal: Research and practice in thrombosis and haemostasis
Published: February 02, 2023

Cangrelor for cardiopulmonary bypass in delayed-onset heparin-induced thrombocytopenia: a case report.

Cangrelor for cardiopulmonary bypass in delayed-onset heparin-induced thrombocytopenia: a case report.

Journal: Research and practice in thrombosis and haemostasis
Published: December 06, 2022

C-reactive protein and D-dimer in cerebral vein thrombosis: Relation to clinical and imaging characteristics as well as outcomes in a French cohort study.

C-reactive protein and D-dimer in cerebral vein thrombosis: Relation to clinical and imaging characteristics as well as outcomes in a French cohort study.

Journal: Research and practice in thrombosis and haemostasis
Published: July 25, 2022

Lack of the human choline transporter-like protein SLC44A2 causes hearing impairment and a rare red blood phenotype.

Lack of the human choline transporter-like protein SLC44A2 causes hearing impairment and a rare red blood phenotype.

Journal: EMBO molecular medicine
Published: May 17, 2022
Showing 1-12 of 41

Last Updated: 09/26/2026